Consensus advice will be updated as new evidence becomes available and will provide structure for a clearer future guidance.
“In the absence of registry records, scientific experiments and case reports would be helpful to provide some guidance on optimized drug dosing.
But as in this guide, observational data is obtained from clinical practice, which often includes information not found in scientific experiments or even original clinical trial data, such as treatment of a disease. patients with other comorbidities, multiple medications, and patient diversity — can be very useful for clinical practice,” said senior author Jennifer H. Martin, MBChB, MA, PhD, FRACP, Researchers at the University of Newcastle and the director of the Australian Center for Clinical and Research on Cannabis said.
Source: Medindia
